Moving Beyond the Spreadsheet in Measuring Pharmacy Benefit Value
Many experts have stated that the prescription drug chain is complex and confusing. However, there seems to be a growing [...]
People: Ogilvy names prominent health industry leader Kim Johnson Global CEO of Ogilvy Health
NEW YORK, USA — Ogilvy today announced that health industry leader Kim Johnson has been appointed Global Chief Executive Officer [...]
Health Economics & Outcomes Research (HEOR) Services Market Leading Players Forecast …
The global Health Economics & Outcomes Research (HEOR) Services market highlights industry and market information, technologies, and dominant … Read [...]
PharmacoEconomics Article Highlights Rare Disease Therapeutics Tied to Patient Outcomes
A recent publication considers how treatments for rare diseases are priced according to patient outcomes. The study aims to compare [...]
Moderate Democrats Singled Out by Targeted Drug Pricing Ads
Ad campaigns supporting drug pricing reform are being launched in states with moderate Democrats who may vote against healthcare legislation [...]
Pfizer Heart Failure Medication Lawsuit Ruling Could Broadly Impact Medicare, Lead to Expensive Aduhelm Coverage
Pfizer is seeking legal backing for its plan to pay healthcare costs for Medicare patients taking one of its pricy [...]
PhRMA awards $75,000 to fund initiatives to reduce health inequities
As part of PhRMA’s continuing commitment to build a more just and equitable health care system, we recently awarded $75,000 [...]
PhRMA Commitment to Equity
Strengthening a culture dedicated to patients and equity: A conversation with Vas Narasimhan, CEO of Novartis This year our industry [...]
Watch: Building trust and enhancing clinical trial diversity
On June 22, during The Atlantic’s Health Equity Summit, PhRMA hosted a conversation on clinical trial diversity. PhRMA Chief Operating [...]
Medicare “negotiation” proposals threaten Americans’ access to medicines
While more than 90% of seniors and people with disabilities report that they are very satisfied with their Medicare Part [...]
Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs
Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs. Reportedly, Sanofi is pleased that [...]
Ex-Surgeon General Sounds The Alarm About Covid Testing Drop Off: ‘We Don’t Know What We Don’t Know’
Dr. Jerome Adams, the former U.S. surgeon general under Donald Trump who has become a frequent commentator on the Biden [...]
Congress has a ‘time-limited window’ to shake up drug pricing, employers, health groups say
Congress has a 'time-limited window' to shake up drug pricing, employers, health groups say fkansteiner Wed, 07/14/2021 - 09:35 Read [...]
Cigna Incentive Program Offers $500 to Switch from Biologics to Biosimilars, Drug Savings Could Reach $375 Billion
In an effort to promote biosimilars, Cigna is offering $500 if customers switch to a lower-cost offering. Experts project that [...]
JAMA Article Finds Medicare Overspent on Generics by $2.6 Billion, Costco Delivered Better Value
A recent article published in JAMA Internal Medicine compares Medicare drug spending on generics to Costco. The researchers found that [...]
With sweeping executive order, Biden puts drug pricing, anti-competitive strategies in the crosshairs
With sweeping executive order, Biden puts drug pricing, anti-competitive strategies in the crosshairs fkansteiner Mon, 07/12/2021 - 09:51 Read the [...]
2021 Managed Healthcare Executive Pharmacy Survey Respondents Consider Impact of Federal Legislation on Drug Prices
The final portion of Managed Healthcare Executive’s 2021 Pharmacy Survey focused on federal legislation as a mechanism to reduce prescription [...]
Which Factors Drive Specialty Drug Expenditures?
The Managed Healthcare Executive Pharmacy Survey asked respondents questions related to specialty drug expenditures in 2021. Most of the 225 [...]
CEVR Researcher and Author Dan Ollendorf Discusses QALYs, Reducing Prescription Drug Prices Using Value, and HTAs
Dr. Dan Ollendorf of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University Medical [...]
Will Senate Finance Committee Chair Use Domestic Reference Pricing in Prescription Drug Negotiation Plan?
Allowing Medicare to negotiate prescription drug costs is one method of reducing healthcare costs. Now, Senate Finance Committee Chair Ron [...]
Prescription Drug Prices Increased 3.1% in July 2020 According to GoodRx
GoodRx found that 52 drugs rose in price by 3.1% in July 2020, while no generics upped their prices. Zogenix’s [...]
Vanderbilt and Stanford Professors Discuss 2021 Drug Pricing Reform in JAMA Article, Note Power of Value Assessments and Medicare Negotiation During COVID-19 Pandemic
Dr. Stacie Dusetzina of Vanderbilt University School of Medicine and Dr. Michelle Mello of Stanford Law School and Stanford School [...]
ICER Considers Fair Access Principles as Aduhelm Price Continues to Incense Critics
The Institute for Clinical and Economic Review (ICER) recently published its protocol detailing how it will gauge access to prescription [...]
Despite WHO Recommendation, COVID-19 Drug Too Costly and Inaccessible; Will Roche Give Up Monopoly?
The World Health Organization (WHO) has recommended the use of monoclonal antibody tocilizumab in cases of severe COVID-19 illness. However, [...]
2021 Managed Healthcare Executive Pharmacy Survey Results Include Increased Focus on Price Transparency to Reduce Prescription Drug Costs
Managed Healthcare Executive is publishing the results from its recent survey. According to the more than 225 respondents, reducing drug [...]